SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (4610)7/27/1998 12:46:00 AM
From: wayne nikituk  Respond to of 9523
 
Im an advisor up here in Canada--I enjoy reading the informed posts here. PFE is without question one of the best run companies in the world---its valuation is rich, but reflects the value investors place in consistency of earnings growth as well as the potential for long term, above average eps growth, return on equity,etc.

I've set aside a $50K college fund for my niece and nephew (3 and 7)---and bought two great funds and 150 shares of only one company-- PFE (in at $105). Anyone have any thoughts on whether the PFE investment 15 years from now will largely pay for an education at Cornell or Stanford?? :)



To: BigKNY3 who wrote (4610)7/27/1998 1:38:00 AM
From: Anthony Wong  Read Replies (1) | Respond to of 9523
 
BigKNY3, re. Zeldox, Pfizer said it plans to agree with the FDA on the parameters of an additional clinical study and expects to refile the application late next year. Could you give us an idea how long it takes for the FDA to reach a decision in cases of refiling? Six months or one year? TIA.

Anthony